Ultragenyx Pharmaceutical reported $68K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Acceleron Pharma XLRN:US $ 0.06M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.19M 0.01M
Aptinyx Inc APTX:US $ 677K 8K
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.68M 0M
Epizyme EPZM:US $ 0.01M 0M
Esperion Therapeutics ESPR:US $ 26K 0
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Insmed INSM:US $ 1.15M 119K
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Kyowa Hakko Kirin 4151:JP Y 26745M 0M
Macrogenics MGNX:US $ 0.6M 0M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Moderna Inc MRNA:US 0 0
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 85K 1000